Double Trouble
Dual primary malignancies are more common than previously thought, but management is complex and research is limited.
When Rouslan Kotchetkov, MD, PhD, a hematologist/oncologist at Simcoe Muskoka Regional Cancer Centre in Ontario, Canada, started practicing...
Online Exclusives
USPSTF Announces New Approach to Gender Inclusivity
The U.S. Preventive Services Task Force (USPSTF) published an article in the Journal of the American Medical Association (JAMA), providing an overview of its...
Crizanlizumab Approved for Sickle Cell Disease in the U.K.
Crizanlizumab will become the first new therapy in 20 years to be made available through the U.K.’s National Health Service (NHS) for the treatment...
News
From the Blood Journals
Adding All-Trans Retinoic Acid to Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed...
A combination regimen comprising all-trans retinoic acid (ATRA) plus low-dose rituximab was associated with an 80% overall response rate and a 61% sustained response...
Liso-Cel Shows Promising Safety and Efficacy in Relapsed/Refractory CLL/SLL
In patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), treatment with lisocabtagene maraleucel (liso-cel) was associated with deep, rapid responses...
Multimedia
Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...
Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...
Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...
Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.
Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...
Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...
Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...
Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.
On Location
Pilot Study Finds Remote Monitoring of Patients Undergoing Chemotherapy Feasible
Using technology to monitor outpatients undergoing cancer treatments at home was feasible and led to...
A New Clinical Ladder for Advanced Practitioners Improves Retention, Engagement
Five years after implementing a “clinical ladder” for advanced practitioners (APs), Moffitt Cancer Center reports...
Amino Acids Could Reduce Cancer Treatment–Related Diarrhea
Treatment-related diarrhea is a common adverse event (AE) associated with cancer-directed therapies, negatively affecting patients’...
HPSCs and Hematopoiesis: From Development to Stem Cell Therapies
As part of this year’s Scientific Program, Gay M. Crooks, MBBS, and Christopher M. Sturgeon,...
The Future of Iron Therapeutics
Therapies for disorders of iron metabolism are rapidly progressing beyond venesection, chelation, and nutritional iron...
Blood and Beyond: Irrigating the Clinical Desert
This year’s Blood and Beyond session will be hosted by Nancy Berliner, MD, Editor-in-Chief of Blood,...
Latest Headlines
ASH Directions
ASH Congratulates Three New ASH Executive Committee Members, and more
Congratulations to Three New ASH Executive Committee Members!
The American Society of Hematology (ASH) has announced the election of three new members to its Executive...
ASH Releases Clinical Practice Guidelines on Stem Cell Transplantation in SCD, Honors Donna S....
NEW! ASH Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease
The American Society of Hematology (ASH) has published clinical practice guidelines on...
ASH Remembers Joseph Bertino, National Academy of Medicine Elects Helen Heslop, and more
Remembering Joseph Bertino (1930 – 2021)
Pioneering oncologist Joseph R. Bertino, MD, died on October 11, 2021, at the age of 91.In 1961, Dr. Bertino...
Remembering Elihu “Eli” Estey, Thomas Waldmann, and more
Remembering Elihu (Eli) Estey (1946 - 2021)
Renowned hematologist Elihu (Eli) Estey, MD, died suddenly on October 11, 2021, at the age of 75.After completing...
NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief...
Sarah Cannon Appoints Navneet Majhail as Deputy Physician-in-Chief of Blood Cancers
Sarah Cannon Research Institute has named Navneet Majhail, MD, deputy physician-in-chief of blood cancers...
Double Trouble
Dual primary malignancies are more common than previously thought, but management is complex and research is limited.
When Rouslan Kotchetkov, MD, PhD, a hematologist/oncologist at...
Crossing the Doctor Desert
Hematologists and oncologists are turning to new delivery models and telemedicine to chart a path through these medically underserved areas
Rural Americans make up an...
The National Cancer Act Turns 50
The National Cancer Act of 1971 set the stage for coordination of research across the U.S. and progress that continues to this day.
2021 marks...